MIM
EIDX

MetLife Investment Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

MetLife Investment Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$574K Sell
2020
Q3 		$282K Hold
2020
Q2 		$266K Hold
2020
Q1 		$273K Hold
2019
Q4 		$320K Hold
2019
Q3 		$201K Sell
2019
Q2 		$263K Hold
2019
Q1 		$198K Buy